San Diego, CA -- (SBWIRE) -- 07/07/2014 -- An investigation on behalf of investors of STAAR Surgical Company (NASDAQ:STAA) shares over potential securities laws violations by STAAR Surgical and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of STAAR Surgical Company (NASDAQ:STAA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of STAAR Surgical Company (NASDAQ:STAA) concerning whether a series of statements by STAAR Surgical regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

STAAR Surgical Company reported that its Total Revenue rose from $63.78 million for the 12 months period that ended on Dec. 28, 2012 to $72.22 million for the 12 months period that ended on Jan. 3, 2014 and that its Net Loss of $1.76 million for the 12 months period that ended on Dec. 28, 2012 turned into a Net Income of $0.4 million 12 months period that ended on Jan. 3, 2014.

Shares of STAAR Surgical Company (NASDAQ:STAA) grew from $5.32 per share in April 2013 to as high as $19.35 per share in April 2014.

Then on July 1, 2014, the U.S. Food and Drug Administration (“FDA”) released a copy of a warning letter that it issued STAAR Surgical Company on May 21, 2014.

Shares of STAAR Surgical Company declined to as low as $13.00 per share on July 1, 2014.

On July 3, 2014 NASDAQ:STAA shares closed at $14.15 per share.

Those who purchased shares of STAAR Surgical Company (NASDAQ:STAA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com